AMSF

AMERISAFE, Inc. (AMSF) Analyst Note Date: 2026-06-13 Current Price: $31.32

1. Structural Readiness

Conservative Entry: Not yet defined (awaiting confirmed breakout) Aggressive/Pre-Breakout Entry: N/A (Current price is not at a defined breakout level; price is holding above support) Breakout Level: Not yet fired. Extension: — ATR Current: 2.5% (Productive / Sub-threshold for high volatility, indicating a stable, lower-volatility environment).

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None named at this date. Judgment Framework: This name is being evaluated strictly on setup quality and business fundamentals. There is no secular macro thesis (e.g., "AI-driven insurance," "Green energy transition") attached to AMSF as of 2026-06-13. The conviction must be derived from the operational execution of the "Margin Inflector" archetype and the technical readiness of the coil structure.

3. Business Overview

Company Profile: AMERISAFE, Inc. is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in high-hazard industries. Target Sectors: Construction, trucking, logging and lumber, agriculture, services, manufacturing, and maritime. Policy Base: As of December 31, 2025, the company reported more than 10,200 voluntary business policyholders. Operational Model: The company differentiates itself through a specialized approach to servicing high-hazard industries, aiming for consistent returns across the cycle.

Key Financials (Source: Q1 2026 Earnings & 10-K filings, dated 2026-04-23):

• Premium Growth: Net earned premiums grew 9% year-over-year to $75.1 million in the quarter ended March 31, 2026. Gross premiums written were $88.5 million.
• Profitability: The company delivered a combined ratio of 93.2% and produced operating earnings of $0.50 per share.
• Loss Ratio: The current accident year loss ratio was 72%, consistent with the 72% recorded for the accident year 2025 at 12 months, though slightly elevated from the 71% seen in Q1 2025.
• Expense Ratio: The expense ratio for 2025 was 30.4%, showing continued improvement.
• Renewal Rates: Policy renewal rates on voluntary business were 93.1% in 2025, 94.2% in 2024, and 94.1% in 2023.
• Capital Return: The company declared cash dividends of $0.41 per share (up from $0.39). Additionally, during the three months ended March 31, 2026, the company repurchased 119,959 shares for $4.0 million at an average price of $33.60.

4. Archetype and Conviction

Archetype: Margin Inflector Fit Analysis: The "Margin Inflector" archetype fits AMSF because the company is demonstrating the ability to expand profitability through operational leverage and expense management while maintaining stable loss ratios.

• Evidence of Inflection: The expense ratio improvement (30.4% in 2025) combined with a 9% premium growth rate and a 93.2% combined ratio indicates that the company is successfully converting top-line growth into bottom-line earnings without a corresponding spike in loss costs.
• Valuation Context: The financial spine indicates a forward consensus EPS of $2.10 for FY1 and $2.09 for FY2. At a current price of $31.32, the stock trades at approximately 14.9x forward earnings.
• Conviction Stack:
• Thesis Strength: Low (Tactical only, no macro tailwinds).
• Evidence Quality: High (Consistent premium growth, strong renewal rates, clear expense management).
• Structural Quality: Moderate (Forming coil, stable ATR).
• Setup Readiness: Partial (Forming state requires a breakout confirmation).
• Rerating Potential: Moderate (Dependent on the successful breakout of the forming coil and continued margin expansion).

ATR Context: The current ATR of 2.5% is in the "productive" bucket but sits below the historical "sweet spot" of 4–6%. This suggests the stock is currently in a low-volatility consolidation phase, which is consistent with a "Forming" coil. It does not signal the high volatility often associated with immediate breakout catalysts, but rather a steady accumulation of support.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental: A significant deterioration in the combined ratio (e.g., breaking above 95-96%) or a sharp decline in renewal rates (below 90%) would undermine the "Margin Inflector" thesis.

Strengtheners:

• Technical: A confirmed breakout above the resistance level of the forming coil (price action moving decisively higher with volume).
• Fundamental: Continued premium growth exceeding 9% or further compression of the expense ratio, alongside stable loss ratios.

Evidence Gaps:

• Forward Guidance Specifics: While management expectations are recorded, specific forward-looking guidance for the full year 2026 beyond the Q1 results is not detailed in the provided snippets.
• Macro Environment: No specific data on the current state of the workers' compensation market cycle (e.g., inflation trends in medical costs) is provided for 2026.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: 9% year-over-year net premium growth; 93.2% combined ratio with 30.4% expense ratio; 93.1% renewal rate on voluntary business; active share repurchase program at $33.60. Key risks: Technical setup is only "Forming" and requires a breakout confirmation; ATR of 2.5% is below the historical volatility sweet spot; loss ratio stability (72%) is flat rather than improving; no named macro thesis to provide tailwinds. Sizing hint: Position size should be conservative given the "Forming" state and lack of breakout confirmation; treat as a partial position pending technical resolution. Expected path: Management expectations of continued premium growth and expense ratio improvement should support the stock if the technical structure resolves to a breakout; if the structure fails, the stock may drift lower toward support. Expected horizon: 3 to 6 months for the technical setup to resolve (breakout or invalidation).